The tirzepatide and the pooled or individual control groups had similar overall risks for any cancer
we want to provide a tool that helps you build a sustainable wellness routine you can rely on
(PubMed) Ma JL, Zhang L, Brown LM, et al
MinuteClinic providers can prescribe oral or injectable FDA approved weight-loss medications including: Contrave Liraglutida Orlistat Semaglutida Saxenda Tirzepatide Los medicamentos aprobados por la FDA garantizan seguridad, eficacia y rigurosos estndares de calidad que brindan a nuestros proveedores y pacientes la confianza que necesitan
According to a report on 06/03/2026, Cigna said that beginning 07/01/2026 it will discontinue coverage of GLP-1 weight-loss medications, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound, for roughly 67,700 employees in its U.S
The FDA has been monitoring reports of suicidal thoughts or actions in patients using these medications, which is a serious consideration that requires careful evaluation [5a07]